Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approach.
Ramudo-Cela L, Santana-Martínez S, García-Ramos M, Bergamino M, García-Giustiniani D, Vélez-Vieitez P, Hernández-Hernández JL, García-Ibarbia C, González-Bustos P, Ruíz-Martín P, González-Lozano J, Santomé-Collazo L, Grana-Fernandez A, Cabaleiro-Cerviño P, Ortíz M, Monserrat-Iglesias L.
Ramudo-Cela L, et al. Among authors: hernandez hernandez jl.
Pharmacogenomics J. 2022 May;22(3):180-187. doi: 10.1038/s41397-022-00274-8. Epub 2022 Mar 31.
Pharmacogenomics J. 2022.
PMID: 35361995